# When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/when-to-stop-eculizumab-in-complement-mediated-thrombotic-microangiopathies/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sven R. Olson,Eric Lu,Emilio D. Sulpizio,Joseph J. Shatzel,Jose Rueda,Thomas G. DeLoughery |
| Citations | 57 |
| DOI | 10.1159/000492033 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.karger.com/Article/Pdf/492033 |
| OpenAlex ID | https://openalex.org/W2886695576 |
| PMID | 30110670 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Sven R. Olson](https://scholariq.org/researchers/sven-r-olson/)

## Paper journal

- [American Journal of Nephrology](https://scholariq.org/journals/american-journal-of-nephrology/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.